Literature DB >> 27777254

Mycobacterium chelonae bacteremia in a patient taking infliximab and prednisone.

Caitlin McCallum1, Bijai Johnson2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27777254      PMCID: PMC5135540          DOI: 10.1503/cmaj.150978

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Mycobacterium chelonae--a growing problem in soft tissue infection.

Authors:  Rod J Hay
Journal:  Curr Opin Infect Dis       Date:  2009-04       Impact factor: 4.915

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study.

Authors:  Ashley B Wentworth; Lisa A Drage; Nancy L Wengenack; John W Wilson; Christine M Lohse
Journal:  Mayo Clin Proc       Date:  2012-12-04       Impact factor: 7.616

  4 in total
  1 in total

1.  Mycobacterium chelonae cutaneous infection: An opportunistic disease in an immunosuppressed patient with myasthenia gravis.

Authors:  Joana Granado; Ana Cláudia Miranda; Marco Fernandes; Luís Santos; Kamal Mansinho
Journal:  IDCases       Date:  2020-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.